Procalcitonin
Order Name
PROCALCITN
Test Number: 5700157
Revision Date 01/23/2019
Test Number: 5700157
Revision Date 01/23/2019
| Test Name | Methodology | LOINC Code |
|---|---|---|
|
Procalcitonin
|
Immunofluorescence Assay (IFA) | 33959-8 |
| SPECIMEN REQUIREMENTS | ||||
|---|---|---|---|---|
| Specimen | Specimen Volume (min) | Specimen Type | Specimen Container | Transport Environment |
| Preferred | 2 mL (0.5 mL) | Plasma | Lithium Heparin PST (Light Green Top) | Refrigerated |
| Alternate 1 | 2 mL (0.5 mL) | Serum | Clot Activator SST | Refrigerated |
| Instructions | The same specimen type (serum, plasma) should be used throughout the patient's clinical course. Allow serum to sit for 30 minutes for proper clot formation and to ensure the absence of fibrin in the serum which can interfere with this assay. Separate serum or plasma from cells within 2 hours of collection. Unacceptable Conditions: Specimens collected in citrate anticoagulant. Stability: After separation from cells: Ambient: 24 hours; Refrigerated: 5 days; Frozen: 1 month. |
|||
| GENERAL INFORMATION | |
|---|---|
| Testing Schedule | Sun-Sat |
| Expected TAT | 2-3 Days |
| Clinical Use | Used in the diagnosis of bacteremia and septicemia in adults and children (including neonates), renal involvement in urinary tract infection in children, bacterial infection in neutropenic patients, and in the diagnosis, risk stratification, and monitoring of septic shock, systemic secondary infection post-surgery, as well as in severe trauma, burns, and multiorgan failure. Differential diagnosis of bacterial versus viral meningitis. Differential diagnosis of community-acquired bacterial versus viral pneumonia. Monitoring of therapeutic response to antibacterial therapy. |
| CPT Code(s) | 84145 |
| Lab Section | Chemistry |